IFF Pharma Solutions announced the launch of Low Nitrite METHOCEL™ hydroxypropyl methylcellulose (HPMC), a new range of low nitrite cellulose ethers. These products are developed to reduce the risk of nitrosamine formation in finished pharmaceutical dosages.
This innovative product line addresses the pharmaceutical industry's concern with nitrosamine risk and mitigation strategies. IFF Pharma Solutions ensures minimal nitrite content by limiting and measuring levels in every batch through enhanced process controls and analytical science.
Each batch of Low Nitrite METHOCEL™ is tested to ensure nitrite levels are consistently at or below 200 parts per billion, providing reliability and performance for controlled and immediate release formulations. This launch reinforces IFF's commitment to quality and safety in drug development.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.